An analysis of patients who received warfarin found the presence of atrial fibrillation significantly increased the risk of dementia.

Patients with atrial fibrillation had a significantly higher rate of total dementia, Alzheimer’s disease…

The FDA approved the Visia AF MRI SureScan and Visia AF single-chamber implantable cardioverter defibrillators (ICDs) on May 2 to treat patients with atrial fibrillation.

Medtronic …

The FDA approved the ImageReady MR-conditional pacing system on April 25 to treat patients with bradycardia.

The system from Boston Scientific …

The FDA approved Medtronic’s Micra Transcatheter Pacing System (TPS) on April 6.

The device is the first commercially…

The Heart Rhythm Society (HRS) announced it would award up to $500,000 in grants for atrial fibrillation and stroke prevention research aimed at addressing National Quality Improvement priorities.

Boehringer Ingelheim Pharmaceuticals is …

The International Board of Rhythm Heart Examiners (IBRHE) announced on March 22 that three people had received awards for volunteering their time and making significant contributions to the organization.

The…

An FDA advisory panel recommended against the approval of the AngelMed Guardian system, an implantable cardiac monitor, designed to detect rapid changes in the heart’s electrical signal caused by a coronary artery occlusion.

The Circulatory…

Boston Scientific and the Mayo Clinic announced on March 16 that they would continue to…

A disconnect between best care and what Medicare is willing to reimburse for it has put some electrophysiologists and their hospitals in a bind. By charging Medicare for what they deem to be medically necessary implantable cardioverter-…

The FDA approved Boston Scientific’s Acuity X4 quadripolar left ventricular leads on Feb. 23.

In April 2014, Boston Scientific …

The Department of Justice (DOJ) announced on Feb. 17 that it had reached settlements worth a total of more than $23 million with 51 hospitals in 15 states for allegedly improperly implanting implantable cardioverter defibrillators (ICDs) cardiac…

The FDA approved St. Jude Medical’s…

Abbott announced on Feb. 2 that it acquired Kalila Medical, a privately held company that develops medical devices to treat atrial fibrillation and other heart rhythm disorders. Terms of the deal were not disclosed.

In 2014, the FDA granted…

Medtronic will present data on its Micra Transcatheter Pacing System to an FDA advisory committee on Feb. 18. The Micra, a…

Sandeep Jauhar, MD, a cardiologist with North Shore-Long Island Jewish Health System, wrote an op-ed in the New York Times recommending electrocardiogram screening for some college athletes. 

In the U.S. athletics,…

St. Jude Medical announced on Jan. 22 that the FDA had classified a previous voluntary recall of the company's Optisure dual coil defibrillation leads as a Class 1 device recall.

On Nov. 3, 2015, St. Jude Medical …

The American National Standards Institute (ANSI) renewed the International Board of Rhythm Heart Examiners (IBHRE) accreditation and certification programs, according to an IBHRE news release.

The IBHRE, an affiliate of the Heart Rhythm…

Adults with heart failure who received implantable cardioverter defibrillators (ICDs) for primary prevention had a significant survival advantage compared with those who did not receive ICDs, according to a propensity score-matched analysis of…

Months after the U.S. Food and Drug Administration (FDA) approved a device with the potential to close the source of many atrial fibrillation-related strokes, hospitals, cardiologists and patients find themselves in a holding pattern increasingly…

The FDA approved the ProMRI implantable cardioverter defibrillator (ICD) systems for use with full-body MRI scans on Dec. 22.

The …

The FDA approved the LifeVest wearable cardioverter defibrillator (Zoll Lifecor Corp.) on Dec. 17 to treat some children who are at risk for sudden cardiac arrest. The device was approved in 2001 for adults who were at least 18 years old.

…